Sidley Ranked in Chambers UK 2027

Sidley has been recognized with 14 practice rankings and 49 lawyer rankings in the Chambers UK 2027 guide. Each year, Chambers and Partners conducts in-depth interviews with thousands of lawyers and clients to identify the top lawyers, legal departments, and law firms in the United Kingdom.

Sidley’s London office — the firm’s largest in Europe — is a key hub for Sidley’s cross-border work, and firm lawyers represent global businesses on their most complex matters across a variety of industries and areas of law.

Significantly, Tom Thesing has been ranked as an Eminent Practitioner in Corporate/M&A: £100-800 million (London). This recognition, which is reserved for “highly influential lawyers in a particular practice area,” is an acknowledgement of Tom’s ability to balance his active practice with his leadership roles within the firm, including his position as managing partner of Sidley’s London office and his roles on Sidley’s Management and Executive Committees.

Furthermore, the following lawyers have been ranked in Band 1 in their respective fields, indicating their status as leading lawyers in the market:

• Sara George – Financial Crime: Individuals (London); Financial Services: Contentious Regulatory (Individuals) (UK-wide)
• Clive Gringras – Artificial Intelligence (UK-wide); IT & Outsourcing: Disputes Specialists (London)
• Philip Hertz – Restructuring/Insolvency (London)
• Leonard Ng – Financial Services: Non-contentious Regulatory (UK-wide)
• Jayanthi Sadanandan – Leveraged Finance: Big Ticket (London)

Sidley has been ranked in the following areas:

• Capital Markets: Debt (UK-wide)
• Capital Markets: High-Yield Products (UK-wide)
• Competition Law (London)
• Corporate/M&A: £100-800 million (London)
• Data Protection & Information Law (UK-wide)
• Financial Services: Non-contentious Regulatory (UK-wide)
• Infrastructure (UK-wide)
• Insurance: Non-contentious (UK-wide)
• Investment Funds: Private Equity (UK-wide)
• Leveraged Finance: Borrowers/Sponsors: Big Ticket (London)
• Life Sciences: Regulatory (UK-wide)
• Private Equity: Buyouts: £500 million and above (UK-wide)
• Restructuring/Insolvency (London)
• Tax (London)